SCHEMBL14044964

SCHEMBL14044964

O=C(/C=C/c1ccco1)c1ccco1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.65
MAPT P10636 6/20 0.63
KMT2A Q03164 4/20 0.63
MEN1 O00255 3/20 0.63
RAB9A P51151 3/20 0.63
ALDH1A1 P00352 3/20 0.63
POLB P06746 3/20 0.63
KDM4E B2RXH2 2/20 0.63
NPC1 O15118 2/20 0.62
USP2 O75604 1/20 0.62
PKM P14618 1/20 0.62
RECQL P46063 1/20 0.62
BLM P54132 1/20 0.62
MCL1 Q07820 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
MAOB P27338 4/20 0.61
MAOA P21397 3/20 0.61
LMNA P02545 1/20 0.61
ABCG2 Q9UNQ0 1/20 0.61
ALPL P05186 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL978637 1.00 HCAR2 (0.65) HCAR2MAPTKMT2AMEN1RAB9A
SCHEMBL6993037 0.84 MAPT (0.62) MAPTKMT2AMEN1RAB9AALDH1A1
SCHEMBL6993038 0.84 MAPT (0.62) MAPTKMT2AMEN1RAB9AALDH1A1
SCHEMBL11701729 0.83 MAPT (0.87) HCAR2MAPTKMT2AMEN1RAB9A
SCHEMBL11701738 0.83 MAPT (0.87) HCAR2MAPTKMT2AMEN1RAB9A
SCHEMBL28286931 0.81 CES2 (0.54) HCAR2MAPTKMT2AMEN1RAB9A
SCHEMBL979497 0.80 HCAR2 (0.74) HCAR2MAPTKMT2AMEN1RAB9A
SCHEMBL979495 0.80 HCAR2 (0.74) HCAR2MAPTKMT2AMEN1RAB9A
SCHEMBL7142763 0.80 HCAR2 (0.74) HCAR2MAPTKMT2AMEN1RAB9A
SCHEMBL8290646 0.80 MAPT (0.76) HCAR2MAPTKMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9290427-B2 Anti-invasive compounds UNIVERSITEIT GENT (BE) 2016-03-22 US claimed
US-20150011620-A1 ANTI-INVASIVE COMPOUNDS UNIVERSITEIT GENT (BE) 2015-01-08 US claimed
EP-2810198-A1 ANTI-INVASIVE COMPOUNDS Universiteit Gent (BE) 2014-12-10 EP claimed
WO-2013113722-A1 ANTI-INVASIVE COMPOUNDS UNIVERSITEIT GENT (BE) 2013-08-08 WO claimed
EP-2810198-B1 ANTI-INVASIVE COMPOUNDS UNIV GENT (BE) 2023-07-12 EP disclosed
US-11375716-B2 Acetyl-CoA carboxylase modulators MONSANTO TECHNOLOGY LLC (US) 2022-07-05 US disclosed
US-20200214289-A1 ACETYL-COA CARBOXYLASE MODULATORS MONSANTO TECHNOLOGY LLC (US) 2020-07-09 US disclosed
US-10548313-B2 Acetyl-CoA carboxylase modulators MONSANTO TECHNOLOGY LLC (US) 2020-02-04 US disclosed
US-20180070589-A1 ACETYL-COA CARBOXYLASE MODULATORS MONSANTO TECHNOLOGY LLC (US) 2018-03-15 US disclosed
US-9844218-B2 Acetyl-CoA carboxylase modulators MONSANTO TECHNOLOGY LLC (US) 2017-12-19 US disclosed
US-20160130229-A1 ACETYL-COA CARBOXYLASE MODULATORS MONSANTO TECHNOLOGY LLC (US) 2016-05-12 US disclosed
US-9290427-B2 Anti-invasive compounds UNIVERSITEIT GENT (BE) 2016-03-22 US disclosed
US-20150011620-A1 ANTI-INVASIVE COMPOUNDS UNIVERSITEIT GENT (BE) 2015-01-08 US disclosed
WO-2014201326-A1 ACETYL-COA CARBOXYLASE MODULATORS MONSANTO TECHNOLOGY LLC (US) 2014-12-18 WO disclosed
EP-2810198-A1 ANTI-INVASIVE COMPOUNDS Universiteit Gent (BE) 2014-12-10 EP disclosed
WO-2013113722-A1 ANTI-INVASIVE COMPOUNDS UNIVERSITEIT GENT (BE) 2013-08-08 WO disclosed
US-7432303-B2 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states Bowen, J. Phillip (US) 2008-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130229-A1 ACETYL-COA CARBOXYLASE MODULATORS ACACA, ACACB, ACAT2 HCAR2 672/4885MAPT 2150/4885KMT2A 1738/4885
US-11375716-B2 Acetyl-CoA carboxylase modulators ACACA, ACACB, ACAT2 HCAR2 672/4885MAPT 2150/4885KMT2A 1738/4885
US-10548313-B2 Acetyl-CoA carboxylase modulators ACACA, ACACB, ACAT2 HCAR2 672/4885MAPT 2150/4885KMT2A 1738/4885
US-20200214289-A1 ACETYL-COA CARBOXYLASE MODULATORS ACACA, ACACB, ACAT2 HCAR2 672/4885MAPT 2150/4885KMT2A 1738/4885
US-20150011620-A1 ANTI-INVASIVE COMPOUNDS MMP3, MMP10, MIF HCAR2 2051/4885MAPT 3571/4885KMT2A 4319/4885
US-20180070589-A1 ACETYL-COA CARBOXYLASE MODULATORS ACACA, ACACB, ACAT2 HCAR2 672/4885MAPT 2150/4885KMT2A 1738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.